159 related articles for article (PubMed ID: 2434524)
41. Characterization of monoclonal antibodies that react with unique and cross-reacting determinants of cholera enterotoxin and its subunits.
Holmes RK; Twiddy EM
Infect Immun; 1983 Dec; 42(3):914-23. PubMed ID: 6196297
[TBL] [Abstract][Full Text] [Related]
42. Killer antibodies in fungal infections.
Conti S; Magliani W; Fisicaro P; Dieci E; Arseni S; Salati A; Polonelli L
Res Immunol; 1998; 149(4-5):334-43; discussion 523. PubMed ID: 9720951
[No Abstract] [Full Text] [Related]
43. Idiotypic vaccination: immunoprotection mediated by anti-idiotypic antibodies with antibiotic activity.
Polonelli L; Lorenzini R; De Bernardis F; Gerloni M; Conti S; Morace G; Magliani W; Chezzi C
Scand J Immunol; 1993 Jan; 37(1):105-10. PubMed ID: 8418467
[TBL] [Abstract][Full Text] [Related]
44. The yeast killer phenomenon: a hypothetical way to control Pneumocystis carinii pneumonia.
Cailliez JC; Séguy N; Aliouat EM; Polonelli L; Camus D; Dei-Cas E
Med Hypotheses; 1994 Sep; 43(3):167-71. PubMed ID: 7815973
[TBL] [Abstract][Full Text] [Related]
45. Four different monoclonal antibodies against type C1 toxin of Clostridium botulinum.
Oguma K; Agui T; Syuto B; Kimura K; Iida H; Kubo S
Infect Immun; 1982 Oct; 38(1):14-20. PubMed ID: 6183207
[TBL] [Abstract][Full Text] [Related]
46. [Demonstration of β-1,2 mannan structures expressed on the cell wall of Candida albicans yeast form but not on the hyphal form by using monoclonal antibodies].
Aydın C; Ataoğlu H
Mikrobiyol Bul; 2015 Jan; 49(1):66-76. PubMed ID: 25706732
[TBL] [Abstract][Full Text] [Related]
47. Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine.
Pettoello-Mantovani M; Nocerino A; Polonelli L; Morace G; Conti S; Di Martino L; De Ritis G; Iafusco M; Guandalini S
Gastroenterology; 1995 Dec; 109(6):1900-6. PubMed ID: 7498655
[TBL] [Abstract][Full Text] [Related]
48. Production and characterization of monoclonal antibodies to tetanus toxin.
Sheppard AJ; Cussell D; Hughes M
Infect Immun; 1984 Feb; 43(2):710-4. PubMed ID: 6198285
[TBL] [Abstract][Full Text] [Related]
49. Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay.
Shone C; Wilton-Smith P; Appleton N; Hambleton P; Modi N; Gatley S; Melling J
Appl Environ Microbiol; 1985 Jul; 50(1):63-7. PubMed ID: 3927840
[TBL] [Abstract][Full Text] [Related]
50. Preparation and characterization of a monoclonal antibody against mannoprotein of Candida albicans.
Farahnejad Z; Rasaee MJ; Moghadam MF; Paknejad M; Kashanian S; Rajabi M
Hybridoma (Larchmt); 2005 Jun; 24(3):146-51. PubMed ID: 15943562
[TBL] [Abstract][Full Text] [Related]
51. Protection of mice against tetanus toxin by combination of two human monoclonal antibodies recognizing distinct epitopes on the toxin molecule.
Ziegler-Heitbrock HW; Reiter C; Trenkmann J; Fütterer A; Riethmüller G
Hybridoma; 1986; 5(1):21-31. PubMed ID: 2420699
[TBL] [Abstract][Full Text] [Related]
52. Monoclonal antibodies that define neutralizing epitopes of pertussis toxin: conformational dependence and epitope mapping.
Lang AB; Ganss MT; Cryz SJ
Infect Immun; 1989 Sep; 57(9):2660-5. PubMed ID: 2474500
[TBL] [Abstract][Full Text] [Related]
53. Isolation and nucleotide sequences of the genes encoding killer toxins from Hansenula mrakii and H. saturnus.
Kimura T; Kitamoto N; Matsuoka K; Nakamura K; Iimura Y; Kito Y
Gene; 1993 Dec; 137(2):265-70. PubMed ID: 8299957
[TBL] [Abstract][Full Text] [Related]
54. Production of monoclonal antibodies with haemagglutination-inhibition activity to the Skalica strain from the tick-borne encephalitis complex.
Novák M; Gresíková M; Sekeyová M; Russ G; Zikán J; Pospísil M; Ciampor F
Acta Virol; 1983 Jan; 27(1):34-42. PubMed ID: 6133429
[TBL] [Abstract][Full Text] [Related]
55. Candida parapsilosis-specific monoclonal antibodies and their use for detection of Candida antigens in experimental systemic candidiasis.
Wong SF; Mak JW
Hybridoma (Larchmt); 2010 Dec; 29(6):539-46. PubMed ID: 21117988
[TBL] [Abstract][Full Text] [Related]
56. From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy.
Polonelli L; Magliani W; Ciociola T; Giovati L; Conti S
Antonie Van Leeuwenhoek; 2011 Jan; 99(1):35-41. PubMed ID: 20714805
[TBL] [Abstract][Full Text] [Related]
57. Protective murine monoclonal antibodies to tetanus toxin.
Shang HF; Liau MY; Chow MF; Jiang SY; Chen SC; Yeh MY
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Nov; 21(4):199-209. PubMed ID: 3151481
[TBL] [Abstract][Full Text] [Related]
58. [The isolation of monoclonal antibodies to Cryptococcus neoformans antigens].
Khrapova NP; Lesovoĭ VS; Prokhvatilova EV; Stupenko LN; Zharkova SF
Zh Mikrobiol Epidemiol Immunobiol; 1999; (6):70-4. PubMed ID: 10876856
[TBL] [Abstract][Full Text] [Related]
59. Effect of Pichia anomala killer toxin on Candida albicans.
Mathews HL; Conti S; Witek-Janusek L; Polonelli L
Med Mycol; 1998 Aug; 36(4):199-204. PubMed ID: 9776835
[TBL] [Abstract][Full Text] [Related]
60. Killer toxins of certain yeast strains have potential growth inhibitory activity on gram-positive pathogenic bacteria.
Izgü F; Altinbay D
Microbios; 1997; 89(358):15-22. PubMed ID: 9218351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
